Possible involvement of catalase in the protective effect of interleukin-6 against 6-hydroxydopamine toxicity in pc12 cells

Brain Research Bulletin

Volumn 43, Issue 6, 1997, Pages 573-577

  Yamada, Kiyofumi ^a   Umegaki, Hiroyuki ^a   Maezawa, Izumi ^a   Iguchi, Akihisa ^a   Kameyama, Tsutomu ^b   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Catalase; Cytokine; Free radicals; Neurotoxicity; NGF

Indexed keywords

AMITROLE; BASIC FIBROBLAST GROWTH FACTOR; BUCLADESINE; CATALASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LEUKEMIA INHIBITORY FACTOR; NERVE GROWTH FACTOR; OXIDOPAMINE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DOPAMINE UPTAKE; DOSE TIME EFFECT RELATION; ENZYME BINDING; ENZYME REGULATION; ENZYME RELEASE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CATALASE; CYTOKINES; INTERLEUKIN-6; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PC12 CELLS; RATS;

EID: 0030744643     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(96)00336-X     Document Type: Article

References (29)

1. Abraham C. R., Selkoe D. J., Potter H. Immunohistochemical identification of the serine protease inhibitor alpha-1 antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:1988;487-501.
2. Arauji D. M., Cotman C. W. Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: Potential involvement of glial-derived factors. Brain Res. 600:1993;49-55.
3. Bauer J., Strauss S., Schreiter-Grasser U., Ganter U., Schlegel P., Witt I., York B., Berger M. Interleukin-6 and α2 -macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285:1991;111-114.
4. Blum-Degen D., Müller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. Interleukin- 1β and inteleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202:1995;17-20.
5. Brenneman D. E., Schultzberg M., Barfai T., Gozes I. Cytokine regulation of neuronal survival. J. Neurochem. 58:1992;454-460.
6. Giulian D., Young D. G., Woodward J., Brown D. C., Lachman L. B. Interleukin-1 is an astroglial growth factor in the developing brain. J. Neurosci. 8:1988;709-714.
7. Fagarasan M. O., Aisen P. S. IL-1 and anti-inflammatory drugs modulate Aβ cytotoxicity in PC12 cells. Brain Res. 723:1996;231-234.
8. Hama T., Kushima Y., Miyamoto M., Kubota M., Takei N., Hatanaka H. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience. 40:1991;445-452.
9. Hama T., Miyamoto M., Tsukui H., Nishio C., Hatanaka H. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci Lett. 104:1989;340-344.
10. Jackson G. R., Apffel L., Werrbach-Perez K., Perez-Polo J. R. Role of nerve growth factor in oxidant-antioxidant balance and neuronal injury. I. Stimulation of hydrogen peroxide resistance. J. Neurosci. Res. 25:1990;360-368.
11. Kamegai M., Niijima K., Kunishita T., Nishizawa M., Ogawa M., Araki M., Ueki A., Konishi Y., Tabira T. Interleukin 3 as a trophic factor for central cholinergic neurons in vitro and in vivo. Neuron. 2:1990;429-436.
12. Kumar R., Agarwal A. K., Seth P. K. Free radical-generated neurotoxicity of 6-hydroxydopamine. J. Neurochem. 64:1995;1703-1707.
13. Mattson M. P., Cheng B., Smith-Swintosky V. L. Neurotrophic factor mediated protection from excitotoxicity and disturbances in calcium and free radical metabolism. Semin. Neurosci. 5:1993;295-307.
14. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., Nagatsu T. Interleukin- 1β , interleukin-6, epidermal growth factor and transforming growth factor- α are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180:1994;147-150.
15. Nakafuku M., Kaziro Y. Epidermal growth factor and transforming growth factor- α can induce neuronal differentiation of rat pheochromocytoma PC12 cells under particular culture conditions. FEBS Lett. 315:1993;227-232.
16. Ortiz de Montellano P. R., Kerr D. E. Inactivation of catalase by phenylhydrazine: Formation of a stable aryl-iron heme complex. J. Biol. Chem. 258:1983;10558-10563.
17. Pittman R. N., Wang S., DiBenedetto A. J., Mills J. C. A system for characterizing cellular and molecular events in programmed neuronal cell death. J. Neurosci. 13:1993;3669-3680.
18. Rukenstein A., Rydel R. E., Green L. A. Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J. Neurosci. 11:1991;2552-2563.
19. Schöbitz B., Voorhuis D. A., De Kloet E. R. Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Neurosci. Lett. 136:1992;189-192.
20. Shimojo M., Imai Y., Nakajima K., Mizushima S., Uemura A., Kohsaka S. Interleukin-2 enhances the viability of primary cultured rat neocortical neurons. Neurosci Lett. 151:1993;170-173.
21. Spina M. B., Squinto S. P., Miller J., Lindsay R. M., Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: Involvementof glutathione system. J. Neurochem. 59:1992;99-106.
22. Tiffany-Castiglioni E., Saneto R. P., Proctor P. H., Perez-Polo J. R. Participation of active oxygen species in 6-hydroxydopamine toxicity to ahuman neuroblastoma cell line. Biochem. Pharmacol. 31:1982;181-188.
23. Tiffany-Castiglioni E., Perez-Polo J. R. Stimulation of resistance to 6-hydroxydopamine in a human neuroblastoma cell line by nerve growth factor. Neurosci. Lett. 26:1981;157-161.
24. Umegaki H., Yamada K., Naito M., Kameyama T., Iguchi A., Nabeshima T. Protective effect of inteleukin-6 against the death of PC12 cells caused by serum deprivation or by the addition of a calcium ionophore. Biochem. Pharmacol. 52:1996;911-916.
25. Vandenabeele P., Fiers W. Is amyloidgenesis during Alzheimer's disease due to an IL-1/IL-6-mediated '́ phase response` in the brain? Immunol. Today. 12:1991;217-219.
26. Walicke P., Varon S., Manthrope M. Purification of a human red blood cell protein supporting the survival of cultured CNS neurons, and its identification as catalase. J. Neurosci. 6:1986;1114-1121.
27. Yamada M., Hatanaka H. Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res. 643:1994;173-180.
28. Yamada K., Kono K., Umegaki H., Yamada K., Iguchi A., Fukatsu T., Nakashima N., Nishiwaki H., Shimada Y., Sugita Y., Yamamoto T., Hasegawa T., Nabeshima T. Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia. Neurosci Lett. 186:1995;219-221.
29. Zhang Y., Tatsuno T., Carney J. M., Mattson M. P. Basic FGF, NGF and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J. Cereb. Blood Flow Metab. 13:1993;378-388.